MARKET

UCBJF

UCBJF

Ucb Sa
OTCPK
259.59
NaN%
Closed 09:30 09/03 EDT
OPEN
--
PREV CLOSE
259.59
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
339.77
52 WEEK LOW
217.49
MARKET CAP
49.49B
P/E (TTM)
20.10
1D
5D
1M
3M
1Y
5Y
1D
Trump unveils new drug-pricing accords with CSL, Astellas, and other biotech drugmakers
Seeking Alpha · 2d ago
Corvus Pharmaceuticals: Steady As She Goes With Strong Footing In Atopic Dermatitis Treatment
Seeking Alpha · 08/27 16:29
Protagonist upgraded at Goldman Sachs on potential of autoimmune asset
Seeking Alpha · 08/10 15:42
TD Cowen Reaffirms Their Buy Rating on UCB SA (0NZT)
TipRanks · 08/04 08:57
UBS Sticks to Its Buy Rating for UCB SA (0NZT)
TipRanks · 08/04 08:56
Stacy Ku Initiates Buy on UCB, Citing Attractive Valuation and Early Bimzelx-Driven Growth Inflection
TipRanks · 08/03 08:55
UCB upgraded to Hold from Underperform at Jefferies
TipRanks · 08/03 08:20
Barclays Sticks to Their Hold Rating for UCB SA (0NZT)
TipRanks · 08/03 07:15
More
About UCBJF
Ucb SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. In the area of central nervous system disorders, the Company is focused on epilepsy, diabetic neuropathic pain, multiple sclerosis, fibromyalgia, restless legs syndrome and Parkinson’s disease, and the area of immunology includes, bone loss disorders, Crohn’s disease, rheumatoid arthritis and respiratory disease. In addition to its core fields of business, Ucb SA delivers molecule solutions to specialists for use in the treatment of severe diseases. Its product portfolio includes drugs, such as Neupro, Vimpat, Cimzia, among others. Ucb SA also operates in primary care to support specialist products that are administered by primary care physicians.

Webull offers UCB SA stock information, including OTCPK: UCBJF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, UCBJF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading UCBJF stock methods without spending real money on the virtual paper trading platform.